List of Oncology Medication For

Solid Tumors

Treatment for solid tumors depends on several factors, including the type and stage of the tumor, its location, and the patient’s overall health. Treatment options may include surgery to remove the tumor, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches.

Ipilimumab Injection

Gastrointestinal, Skin

ipilimumab injection,
for intravenous use Initial U.S. Approval: 2011

Yervoy (ipilimumab) is a kinase inhibitor indicated for the treatment of advanced (unresectable or metastatic) melanoma.

Facts about Ipilimumab Injection

API: ipilimumab
Trade Name: On Request
Packaging: injection, for intravenous use
Strength: Injection: 50 mg/10 mL (5 mg/mL) and 200 mg/40 mL (5 mg/mL) in a single-use vial.
DISEASE INDICATIONS-Urothelial Carcinoma, Skin Cancer
MANUFACTURER-Bristol-Myers Squibb
USAGE-Intravenous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Pharmaceuticals and Medical Devices Agency (PMDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Ipilimumab Injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Ixekizumab injection

Skin

ixekizumab injection
for subcutaneous use Initial U.S. Approval: 2016

ixekizumab injection is a humanized interleukin-17A antagonist indicated for the treatment of: • patients aged 6 years or older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. • adults with active psoriatic arthritis. • adults with active ankylosing spondylitis. • adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation.

Facts about ixekizumab injection

DISEASE INDICATIONS-Psoriasis
MANUFACTURER-Eli Lilly Nederland B.V.
USAGE-Subcutaneous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import ixekizumab injection” based on the information you provide.

IXEMPRA Kit (ixabepilone) for Injection

Breast Cancer

IXEMPRA Kit (ixabepilone) for injection, for intravenous use Initial U.S. Approval: 200

XEMPRA is a prescription medicine. IXEMPRA is used to treat breast cancer. • IXEMPRA, a microtubule inhibitor, in combination with capecitabine is indicated for the treatment of metastatic or locally advanced breast cancer in patients after failure of an anthracycline and a taxane. • IXEMPRA as monotherapy is indicated for the treatment of metastatic or locally advanced breast cancer in patients after failure of an anthracycline, a taxane and capecitabine. .

Brand Name:	IXEMPRA Kit
Generic Name:	ixabepilone
Strength:	• IXEMPRA for injection, 15 mg supplied with DILUENT for IXEMPRA, 8 mL • IXEMPRA for injection, 45 mg supplied with DILUENT for IXEMPRA, 23.5 mL
Manufacturer:	R-Pharm
Approved By:	EMA, USFDA

Source content : www.accessdata.fda.gov

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import IXEMPRA Kit (ixabepilone) for Injection” based on the information you provide.

JAYPIRCA (pirtobrutinib) tablets

Lymphoma, Blood Disorders, Solid Tumors

Brand Name: JAYPIRCA Generic Name: pirtobrutinib JAYPIRCA (pirtobrutinib) is used for treatment of Adult patients with relapsed or refractory mantle cell lymphoma (MCL)

Jaypirca is a cancer medicine used to treat adults with mantle cell lymphoma (a cancer of B cells, a type of white blood cell) whose cancer has come back (relapsed) or no longer responds to treatment (refractory), and who had previously received a type of cancer medicine called a Bruton’s tyrosine kinase (BTK) inhibitor.

Brand Name:	JAYPIRCA
Generic Name:	pirtobrutinib
Strength:	Tablets: 50 mg, 100 mg
Manufacturer:	Eli Lilly and Company
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “JAYPIRCA (pirtobrutinib)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for JAYPIRCA (pirtobrutinib) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

JYLAMVO (methotrexate) oral

Arthritis, Leukemia, Lymphoma

Brand Name: JYLAMVO Generic Name: methotrexate . JYLAMVO (methotrexate) is used to treat ALL, mycosis fungoides, nonHodgkin lymphoma, rheumatoid arthritis and severe psoriasis.

JYLAMVO is a folate analog metabolic inhibitor indicated for the: • Treatment of adults with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen • Treatment of adults with mycosis fungoides • Treatment of adults with relapsed or refractory nonHodgkin lymphoma as part of a metronomic combination regimen • Treatment of adults with rheumatoid arthritis • Treatment of adults with severe psoriasis.

Brand Name:	JYLAMVO
Generic Name:	methotrexate
Strength:	Oral solution: 2 mg/mL
Manufacturer:	Therakind Limited
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “JYLAMVO (methotrexate)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for JYLAMVO (methotrexate) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

KISUNLA (donanemab-azbt) injection

Alzheimers, Chronic Disease, Neuro

Brand Name: KISUNLA Generic Name: donanemab-azbt KISUNLA (donanemab-azbt) is used to treat Alzheimer’s disease.

KISUNLA is an amyloid beta-directed antibody indicated for the treatment of Alzheimer’s disease. Treatment with KISUNLA should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in the clinical trials.

Brand Name:	KISUNLA
Generic Name:	donanemab-azbt
Strength:	Injection: 350 mg/20 mL (17.5 mg/mL) in a single-dose vial.
Manufacturer:	Eli Lilly and Company
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “KISUNLA (donanemab-azbt)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for KISUNLA (donanemab-azbt) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

KRAZATI (adagrasib) tablets

Lung Cancer

KRAZATI (adagrasib) tablets, for oral use Initial U.S. Approval: 2022

Krazati is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) whose tumor has an abnormal KRAS G12C gene. Krazati works as a targeted therapy designed to attack the mutated KRAS protein to suppress tumor growth.

Brand Name:	KRAZATI
Generic Name:	adagrasib
Strength:	Recommended dosage: • 600 mg orally twice daily. • Swallow tablets whole with or without food.
Manufacturer:	Mirati Therapeutics, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “KRAZATI (adagrasib) tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for KRAZATI (adagrasib) tablets price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

KRYXANA (ribociclib) 200 mg Film-coated tablets

Breast Cancer, Solid Tumors

Kryxana (Ribociclib) – Breast Cancer Therapy in India

Kryxana (a cyclin-dependent kinase inhibitor, CDKi) in combination with letrozole is indicated for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, as an initial endocrine-based therapy.

Brand Name:	Kryxana
Generic Name:	ribociclib tablets
Strength:	• Tablets: 200 mg
Manufacturer:	NOVARTIS
Approved By:	EMA, USFDA

Source Details: Patient Information.
Kryxana must always be used under the supervision of a Registered Medical Practitioner (RMP).

Access Kryxana for Breast Cancer

Kryxana 200 mg (ribociclib), marketed by Novartis India Ltd, is available in India. Patients can access this medicine for personal use through authorized channels. IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors. To proceed, the applicant must submit an application with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.

LAMZEDE (velmanase alfa-tycv) Injection

Neuro

Brand Name: LAMZEDE. Generic Name: (velmanase alfa-tycv). LAMZEDE (velmanase alfa-tycv) is used to treat non-central nervous system manifestations of alpha-mannosidosis.

LAMZEDE is an that is used for the treatment of adult and pediatric patients with alpha-mannosidosis. Alpha-mannosidosis is a rare disease where patients have decreased activity of the enzyme alpha-mannosidase, which breaks down mannose containing oligosaccharides (a complex sugar).

Brand Name:	LAMZEDE
Generic Name:	velmanase alfa-tycv
Strength:	For injection: 10 mg of velmanase alfa-tycv as a lyophilized powder in a single-dose vial for reconstitution.
Manufacturer:	Chiesi USA, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “LAMZEDE (velmanase alfa-tycv)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for LAMZEDE (velmanase alfa-tycv) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Lanadelumab-flyo injection

Skin

lanadelumab-flyo injection
for subcutaneous use. Initial U.S. Approval: YYYY.

lanadelumab-flyo injection indicated for routine prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older.

Facts about lanadelumab-flyo injection

DISEASE INDICATIONS-Hereditary angioedema (HAE)
MANUFACTURER-Shire Pharmaceuticals
USAGE-Subcutaneous
MEDICINE APPROVED BY-European Medical Agency (EMA),Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “lanadelumab-flyo injection” based on the information you provide.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Solid Tumors

ipilimumab injection, for intravenous use Initial U.S. Approval: 2011

Facts about Ipilimumab Injection

Access the best support services globally

ixekizumab injection for subcutaneous use Initial U.S. Approval: 2016

Facts about ixekizumab injection

Access the best support services globally

IXEMPRA Kit (ixabepilone) for injection, for intravenous use Initial U.S. Approval: 200

Access the best support services globally

Brand Name: JAYPIRCA Generic Name: pirtobrutinib JAYPIRCA (pirtobrutinib) is used for treatment of Adult patients with relapsed or refractory mantle cell lymphoma (MCL)

Brand Name: JYLAMVO Generic Name: methotrexate . JYLAMVO (methotrexate) is used to treat ALL, mycosis fungoides, nonHodgkin lymphoma, rheumatoid arthritis and severe psoriasis.

Brand Name: KISUNLA Generic Name: donanemab-azbt KISUNLA (donanemab-azbt) is used to treat Alzheimer’s disease.

KRAZATI (adagrasib) tablets, for oral use Initial U.S. Approval: 2022

Kryxana (Ribociclib) – Breast Cancer Therapy in India

Access Kryxana for Breast Cancer

Brand Name: LAMZEDE. Generic Name: (velmanase alfa-tycv). LAMZEDE (velmanase alfa-tycv) is used to treat non-central nervous system manifestations of alpha-mannosidosis.

lanadelumab-flyo injection for subcutaneous use. Initial U.S. Approval: YYYY.

Facts about lanadelumab-flyo injection

Access the best support services globally

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

ipilimumab injection,
for intravenous use Initial U.S. Approval: 2011

ixekizumab injection
for subcutaneous use Initial U.S. Approval: 2016

lanadelumab-flyo injection
for subcutaneous use. Initial U.S. Approval: YYYY.